Targeting the High-Mobility Group Box 3 Protein Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
Crossref DOI link: https://doi.org/10.1158/0008-5472.CAN-19-0542
Published Online: 2019-07-01
Published Print: 2019-07-01
Update policy: https://doi.org/10.1158/crossmark_policy
Mukherjee, Anirban
Huynh, Van
Gaines, Kailee
Reh, Wade Alan
Vasquez, Karen M. http://orcid.org/0000-0002-6958-5073
Funding for this research was provided by:
NIH NCI (CA193124 and CA093729)